威尔药业: 威尔药业关于持股5%以上股东股份解质及展期的公告

Core Viewpoint - The announcement details the share pledge and release situation of major shareholders of Nanjing Weier Pharmaceutical Group Co., Ltd, highlighting the changes in shareholding and the implications for the company's capital structure [1]. Share Pledge Extension - Major shareholder Gao Zhengsong has extended the pledge of his shares, which constitutes 45.00% of his total holdings and 4.69% of the company's total share capital [1]. - The extension period for the pledge is set to end on August 21, 2026 [1]. Share Release - Gao Zhengsong has released 211,000 shares, which represents 14.95% of his holdings and 1.56% of the company's total share capital [1]. - Another major shareholder, Tang Qunsong, has released 260,000 shares, accounting for 18.42% of his holdings and 1.92% of the company's total share capital [1]. Cumulative Pledge Situation - The total number of shares pledged by major shareholders amounts to 56,878,443 shares, which is 42.00% of their total holdings [3]. - The cumulative pledged shares include 25,230,000 shares that are subject to restrictions and 23,120,000 shares that are frozen [3].